PrepaCyte®-CB praised by customer in recent industry publication.January 14, 2009
Evaluation of PrepaCyte-CB® as an alternative to hetastarch methods for processing umbilical cord blood samples
Cryobanks International, Inc.,
As the manager of a stem cell processing center, I am always looking for ways to control costs while maintaining, if not improving, the production of the highest quality stem cell products for transplantation…
Following the clinical trial and internal validation, Cryobanks adopted PrepaCyte-CB as a processing system in May 2008. In the clinical study and in our subsequent validation PrepaCyte-CB has consistently provided high quality stem cell products. Additional benefits of efficiency and increased staff utilization made switching to PrepaCyte-CB an easy decision to make…
We believe the PrepaCyte technology allows us to process cord blood units in a safe, reliable manner, consistently achieving the best TNC recovery possible, while helping us manage costs effectively…
~ISCT Telegraft December 2008
To read the entire article, please click HERE. Select the sample copy of Telegraft link near bottom of page and read Tech Talk starting on page 4.